Clinical Trial Details
— Status: Not yet recruiting
Administrative data
| NCT number |
NCT05692102 |
| Other study ID # |
QOLAGM |
| Secondary ID |
|
| Status |
Not yet recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
June 2023 |
| Est. completion date |
June 2025 |
Study information
| Verified date |
January 2023 |
| Source |
Assiut University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Evaluate quality of life after gynaecological malignancies diagnosis and treatment
Description:
gynecological cancers represent 10% of new cancer cases among women The main types are
cervical, endometrial, ovarian and breast cancers. Each of these is unique in terms of
prognosis, treatment, and age at onset.
Early detection and improvement in treatment of these cancers has led to improvements in
survival and, consequently, an increase in the number of survivors However, survival is
accompanied by several negative aspects, such as fatigue, physical changes, sexual
dysfunction, anxiety, and/or depression In addition to the physical and psychological
disorders, survivors of gynecological cancer can experience economic problems related to
work, or access to loans and insurance Although cancer occurs mainly in older adults, some
people, particularly survivors of cervical and ovarian cancer, may experience cancer at an
age where work is still of major importance For these women, a return to work represents a
return to a normal social life and helps them to regain their self-esteem. Furthermore, work
is a source of emotional and financial support and has been shown to enhance health-related
quality of life by its positive effect on self-esteem Therefore, special attention must be
paid to the well-being of survivors of gynecological cancer, as well as to their social and
professional reintegratio is a multidimensional concept which encom passes physical and
mental health as well as social well being. Although in recent decades, several studies have
focused on and its determinants in survivors of gynecological cancer, has mainly been studied
as it pertains to clinical data or with short follow-up durations. Our previous studies in
long-term survivors of breast cancer have shown that the likelihood that will depend on other
factors increases in line with the length of follow-up since diagnosis.
Due to the improvement in medical science and continuing advancement in early detection and
treatment, the expected survival time of cancer patients has become longer. This has resulted
in an increased interest in exploring the health-related quality of life of cancer survivors.
So, there is a consequent need to satisfy cancer patients' requirements which would enable
them to live a healthy life In many cases, cancer patients experience sleep disturbance,
depression and poor quality of life after being diagnosed and treated for cancer. So, the
assessment of QoL among cancer patients is essential in order to design interventions for
improving patients' outcomes Likewise, QoL assessment assists people realize how treatment,
disease, and health impact quality of life. Furthermore, it helps to understand potential
beneficial and risky aspects of a treatment thus help in weighing the impact of a decision
